FDA plans public workshop on ctDNA tests February 14, 2020 -- The U.S. Food and Drug Administration (FDA) is planning to hold a public workshop on March 9 on the development of circulating tumor DNA (ctDNA) tests for cancer screening.
FDA seeks help to prevent vaping-related lung injuries February 14, 2020 -- The U.S. Food and Drug Administration (FDA) has issued a public call for more information to help prevent future vaping-related injuries. The agency is asking for information on substances used by vapers and ways to make vaping products tamper-proof.
CT imaging supplements lab tests for diagnosing coronavirus disease February 13, 2020 -- Computed tomography (CT) was able to detect COVID-19, the disease caused by the 2019 novel coronavirus, in individuals with high clinical suspicion of the virus -- even in cases with negative initial DNA tests -- Chinese researchers reported in a study published online February 12 in the journal Radiology. Discuss
Coronavirus toll surges after sanction of CT diagnosis February 13, 2020 -- The number of new confirmed cases of coronavirus disease (COVID-19) in China hit roughly 15,000 within the past 24 hours alone, a major increase, according to news reports. The surge follows a decision by Chinese officials to expand the diagnostic criteria for COVID-19 to include cases diagnosed with computed tomography (CT). Discuss
Blood test for sex hormone protein signals stroke risk February 13, 2020 -- Low levels of sex hormone binding globulin in blood were associated with higher stroke risk in a new analysis of postmenopausal women who had been enrolled in the Women's Health Initiative study. The results indicate a potential role for hormonal screening as part of managing stroke risk, researchers suggested. Discuss
Coronavirus test gets CMS billing code February 13, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) has developed a billing code in the Healthcare Common Procedure Coding System to be used by labs and facilities testing patients for the novel coronavirus, which is now being called SARS-CoV-2 (formerly 2019-nCoV).